Multifactorial 1, 3, 4‐Oxadiazole Derivatives as Cholinesterase and Glycogen Synthase Kinase‐3 β Inhibitors for Targeting Alzheimer's Disease: QSAR‐Based Virtual Screening, MD Docking, Free Energy Analysis, ADMET, and DFT Studies